There will be no dividend and no buyback.This is a fastrack growth company that will need all the cash it has to invest in the startup costs of all the new contracts they will win.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025